Connor, Clark & Lunn Investment Management (CC&L)’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q4 | – | Sell |
-39,100
| Closed | -$927K | – | 671 |
|
|
2014
Q3 | $927K | Sell |
39,100
-5,100
| -12% | -$121K | 0.01% | 315 |
|
|
2014
Q2 | $1.41M | Sell |
44,200
-65,700
| -60% | -$2.1M | 0.01% | 280 |
|
|
2014
Q1 | $3.21M | Buy |
109,900
+35,800
| +48% | +$1.04M | 0.02% | 213 |
|
|
2013
Q4 | $1.98M | Buy |
74,100
+35,400
| +91% | +$945K | 0.02% | 266 |
|
|
2013
Q3 | $814K | Buy |
+38,700
| New | +$814K | 0.01% | 289 |
|